Up Next
Back to Show
Amanpour & Co.
Jennifer Doudna on FDA Approval of First CRISPR Treatments
More than a decade ago, pioneering biochemist Jennifer Doudna co-invented CRISPR, the gene editing technology which earned her the Nobel Prize in chemistry. Now, the very first treatment based on CRISPR has been approved in the U.K. and the U.S., a landmark decision for the treatment of sickle cell disease and for the potential of this rapidly advancing field. Dr. Doudna joins to discuss.
Support Provided By
Season
Unlock with PBS Passport
55:41
Zvi Solow; Selma van de Perre; Elie Wiesel; Zahra Joya; Jonathan Blitzer
Unlock with PBS Passport
55:46
Stephen Rapp; Angela Patton; Natalie Rae; Eric Schmidt
Unlock with PBS Passport
55:44
Rami Jarrah; Geir Pederson; Jon Finer; Abby Edaburn; Jacob Tice
Unlock with PBS Passport
55:47
Cardinal Blase J. Cupich; Ben Wedeman; Philip Pullella; David Gibson
Unlock with PBS Passport
55:32
Maura Healey; Cyrus Nasseri; Simon Shama
Unlock with PBS Passport
55:47
Kurt Campbell; Marcel Mettelsiefen; Debbie Wei Mullin and Sarah LaFleur
Unlock with PBS Passport
55:40
Michael S. Roth; David Gibson; Kelsey Osgood
Unlock with PBS Passport
55:47
Oleksandr Merezhko; Kholood Khair; Alex Gibney and Jane Mayer; Art Spiegelman
Unlock with PBS Passport
55:41
Ernie Tedeschi; Gregory Mankiw; Vali Nasr; David Culver; Kenneth Stern
Unlock with PBS Passport
55:47
Peter Frankopan; Linder; George Church
Unlock with PBS Passport
55:47
Chris Sununu; Ed Yong; Oren Cass; Gints Zilbalodis
Unlock with PBS Passport
55:47
Li Yuan; Ryan Calais Cameron; Jasmine Mooney